글로벌 연구동향
분자영상 및 방사화학
- 2016년 02월호
[Biomaterials] A highly tumor-specific light-triggerable drug carrier responds to hypoxic tumor conditions for effective tumor treatment.가톨릭대 / 박우람, 나건*
- 출처
- Biomaterials
- 등재일
- 2016 Jan
- 저널이슈번호
- 77:227-34. doi: 10.1016/j.biomaterials.2015.11.014. Epub 2015 Nov 11.
- 내용
AbstractLight-triggered drug delivery is among the most investigated stimulus-response strategies and has been widely explored in cancer treatment. However, the limited specificity of light-triggered drug delivery reduces the therapeutic efficacy and causes considerable undesirable side effects. In this work, we demonstrate a highly tumor-specific light-triggerable drug carrier (H-LTDC) induced by a combination of internal (i.e., tumor hypoxia) and external stimuli (i.e., light). The doxorubicin (DOX)-loaded H-LTDC was self-assembled from type-1-reactive oxygen species (ROStype1)-mediated degradable chondroitin sulfate (CS) conjugated with a photosensitizer (PS), Pheophorbide-a, which has a spherical shape and a uniform size distribution. Under hypoxic conditions, ROSType1 was mainly generated due to the electron-rich sulfate groups in the polysaccharide backbone. The ROStype1 generated by H-LTDC allowed laser-triggered drug release at low oxygen concentrations. From the in vitro cytotoxicity tests with colon cancer cells (HCT-116), under laser irradiation, DOX-loaded H-LTDCs showed higher toxicity under hypoxic conditions than that under normoxic conditions. In vivo and ex vivo biodistribution studies demonstrated that H-LTDCs selectively accumulated in the tumor tissues. As a result, drug-loaded H-LTDCs exhibited high anti-tumor activity in vivo. Overall, we believe that this approach could represent a promising platform for the treatment of tumor and hypoxia-associated diseases without undesirable side effects.
Author information
Park W1, Bae BC1, Na K2.
1Center for Photomedicine, Department of Biotechnology, The Catholic University of Korea, 43 Jibongro, Wonmi-gu, Bucheon-si, Gyeonggi do, 14662, Republic of Korea.
2Center for Photomedicine, Department of Biotechnology, The Catholic University of Korea, 43 Jibongro, Wonmi-gu, Bucheon-si, Gyeonggi do, 14662, Republic of Korea. Electronic address: kna6997@catholic.ac.kr.
- 연구소개
- 본 연구는 빛 이용하여 약물전달체를 이용한 새로운 항암치료법에 관한 것입니다. 기존에 빛을 이용한 약물전달체는 활발한 연구가 되어 왔지만, 햇빛과 같은 외부에 빛에 의해 비선택적으로 약물이 방출되는 부작용을 가지고 있었습니다. 본 연구에서는 빛과 종양조직의 미세환경을 동시에 이용하여 항암의약품 전달체의 종양선택성을 극대화 하였습니다. 본 연구결과를 통하여 기존 항암제의 부작용은 최소화하고 치료효과는 극대화 할 수 있을 것이라 생각합니다.
- 덧글달기